Skip to content

Testimonials

In order to make structural heart procedures more predictable, computational modeling is likely to have a critical role to play.  FEops have successfully developed technology that simulates the interaction between implanted devices and various cardiac structures.  We view this as a very exiting development in interventional cardiology.

Dr Azeem Latib

San Rafaele, Milano, IT

Pre-operatively simulating different scenarios of the intervention will undoubtedly play a key role in further reducing complications for structural heart interventions.

Dr Carlos Ruiz

Hackensack University Medical Center, New York, USA

In order to make structural heart procedures more predictable, computational modeling is likely to have a critical role to play. FEops have successfully developed technology that simulates the interaction between implanted devices and various cardiac structures.  We view this as a very exiting development in interventional cardiology.”

Dr Mark Monaghan

King’s College, London, UK

FEops are leading the way in image segmentation and computer modelling. With an emphasis on structural intervention, new solutions are being developed to enable clinicians to better plan for their procedures and to predict outcomes more robustly than historical geometric data alone.

Dr Ronak Rajani

Guy’s and St Thomas’, London, UK

We created the Computer Modeling and Simulation Project to achieve the delivery of medical product solutions in a responsible, patient-sparing way that balances the desire for certainty in through the use of computer modeling and simulation as valid scientific evidence.”

MDIC* working group on computational modeling & simulation

Arlington, VA, USA

Office of Science and Engineering Laboratories, Center of Devices and Radiological Health, US Food and Drug administration.
The FDA wants to advance the use of computational modeling and simulation for medical devices and supports the development of virtual physiological patients, clinical trial simulations and personalized medicine.”

Tina M. Morrison, Office of Science and Engineering Laboratories, Center for Devices and Radiology Health, US Food and Drug Administration

(FDA)

Ideally, as TAVI becomes standard of care even in low and intermediate risk patients, it would be great to take the guess-work out – to be able to simulate what is going to happen when you put the valve into that anatomy.

Dr Azeem Latib

San Rafaele, Milano, IT